Factors increasing the risk of mortality and morbidity due to coronavirus infection in patients with metabolic syndrome
Patients living with comorbid metabolic syndrome (MS) and metabolic disorders such as obesity and type 2 diabetes mellitus carry increased levels of circulating cytokines and systemic low-grade inflammation. Upon viral infection, such patients with all pre-existing backgrounds, specifically dysregul...
Main Authors: | Altansuvd Enkhtur, Joon-Sup Yoon, Chang-Woo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Sungkyunkwan University School of Medi
2020-09-01
|
Series: | Precision and Future Medicine |
Subjects: | |
Online Access: | http://www.pfmjournal.org/upload/pdf/pfm-2020-00121.pdf |
Similar Items
-
Embryonic hematopoiesis modulates the inflammatory response and larval hematopoiesis in Drosophila
by: Wael Bazzi, et al.
Published: (2018-07-01) -
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01) -
Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic Function
by: Aisling O’Brien, et al.
Published: (2021-06-01) -
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021-01-01) -
Knockdown of menin affects pre-mRNA processing and promoter fidelity at the interferon-gamma inducible <it>IRF1 </it>gene
by: Auriemma Lauren B, et al.
Published: (2012-01-01)